Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us Membership Collaborators Partners
OPEN ACCESS

Retraction: Electroacupuncture-assisted Ribavirin Dosing for Long COVID: A Randomized Controlled Trial

Future Integrative Medicine   2025

doi: 10.14218/FIM.2024.00043R

Published online:

 Author information

Citation: . Retraction: Electroacupuncture-assisted Ribavirin Dosing for Long COVID: A Randomized Controlled Trial. Future Integr Med. Published online: Jun 6, 2025. doi: 10.14218/FIM.2024.00043R.

Retraction: Djumaeva N, Djumaeva L, Akhundjanova G, Urunova D. Electroacupuncture-assisted Ribavirin Dosing for Long COVID: A Randomized Controlled Trial. Future Integr Med 2024;3(4):215–221. doi: 10.14218/FIM.2024.00043.

The above article, published online on 23 December 2024 in Xia & He Publishing Inc. (https://www.xiahepublishing.com ), has been retracted by agreement between the Editor-in-Chief, Jiabo Wang, and Xia & He Publishing Inc.

Following an internal review, it was found that this randomized controlled trial lacked registration in a recognized public clinical trial registry, as required by the journal’s policy and the recommendations of the International Committee of Medical Journal Editors (ICMJE). Despite multiple attempts to contact the authors and their affiliated institution to request a valid registration number or clarification, no response has been received. In the absence of such registration, the compliance with accepted ethical standards cannot be verified.

In accordance with best practices in scholarly publishing and to maintain the integrity of the scientific record, the editor and the publisher have decided to retract the article.

The authors were informed of the decision to retract the article but did not provide a response.

About this Article

Cite this article
. Retraction: Electroacupuncture-assisted Ribavirin Dosing for Long COVID: A Randomized Controlled Trial. Future Integr Med. Published online: Jun 6, 2025. doi: 10.14218/FIM.2024.00043R.
Copy Export to RIS Export to EndNote
Article History
Received Revised Accepted Published
June 6, 2025
DOI http://dx.doi.org/10.14218/FIM.2024.00043R